跳至主要内容
临床试验/ACTRN12619001478101
ACTRN12619001478101已完成4 期

MenGO: Does the licensed meningococcal vaccine Bexsero® provide cross- protection against gonorrhoea in gay and bisexual men?

Gold Coast Hospital and Health Service0 个研究点目标入组 130 人开始时间: 2019年10月25日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Male

入选标准

  • Participants can be included in the study if they are:
  • Older than>18 years of age
  • Able to understand spoken and written English
  • Male who has sex with other men
  • Able to participate in study procedures including attending for all study visits
  • At risk of acquisition of gonorrhoea at the time of enrolment into the study
  • Agree to be contacted via phone/ email by the study team
  • Currently taking HIV pre-exposure prophylaxis (PrEP) at the time of enrolment OR
  • Been diagnosed with gonorrhoea in the last 3 months

排除标准

  • Patients will be excluded from participation if they have:
  • Confirmed previous history of vaccination for Meningococcal B with Bexsero®)
  • Contraindications to receiving the Meningococcal B vaccine which include:
  • Anaphylaxis following a previous dose of any meningococcal vaccine
  • Anaphylaxis following any vaccine component
  • (previous meningococcal disease and previous vaccination with the strain specific meningococcal B vaccine MeNZB is not a contraindication for receiving Bexsero®)

研究者

相似试验